Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literature

SIMPLE SUMMARY: In the last decades, tremendous advances have been made in understanding HER2-positive breast cancer biology, with a progressive improvement in survival rates of patients with this breast cancer subtype. However, a not negligible proportion of patient with HER2-positive breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanopoulou, Eirini, Khader, Leila, Caira, Morena, Wardley, Andrew, Ettl, Johannes, Miglietta, Federica, Neven, Patrick, Guarneri, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696181/
https://www.ncbi.nlm.nih.gov/pubmed/33182657
http://dx.doi.org/10.3390/cancers12113317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696181/
https://www.ncbi.nlm.nih.gov/pubmed/33182657
http://dx.doi.org/10.3390/cancers12113317

Ejemplares similares